Login
1 active alerts
Show
Research Administration Education Series
A focus on areas of patient-oriented education..
Research Administration Education Series (R.A.E.S)
| The Research Administration Education Series seeks to effectively engage both experts and novices while providing educational content for the adult learner in an innovative manner, using evidence-based practice, drawing on new research practice literature, and fostering an environment of collegial, collaborative knowledge sharing between multiple departments. | ||
| Subject Area | Level | |
|---|---|---|
| Research Methods | Intermediate | |
| Audience | Delivery | |
| Clinical or healthcare delivery science researchers, research nurses/coordinators, nursing staff, research staff, investigational pharmacists, study team members actively involved in the research process or those who intend to begin a research project and seek to effectively engage in the research process; other interested clinicians and staff. | Didactic and experiential learning. | |
| Requirements | Pre-Requisites | |
| Recommended for researchers, research nurses, study coordinators, and/or other interested individuals. | None. | |
| Credits/Certification | Length | |
| For information about education credits contact the course director | 1 hour. | |
| Date(s) | Registration | |
| On the 4th Tuesday of every other month from 12:00pm to 1:00pm via Microsoft Teams | Upcoming sessions will be announced on Caregiver Connect. | |
| Fee(s) | Contact Information | |
| No charge for ChristianaCare employees, Medical-Dental staff and credentialed providers. | Rosymar Magana, MPH, CHES. Institutional Review Board/Research Ed Specialist, (302) 623-4985 | |
Contact iLead
John H. Ammon Medical Education Center
2nd Floor, Suite 2E65A
4755 Ogletown-Stanton Road
Newark, DE 19718 - directions
Phone: 302-733-5943
Related Content
The DE-INBRE program advances research in key areas including cancer and heart disease, bringing cutting-edge treatments to improve the health of Delawareans.
Global audience in Copenhagen, Denmark, will learn of Gene Editing Institute research targeting the NRF2 gene in cancer cells